awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB
Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB
Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
P2860
Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37731964-30E23C37-A437-4E33-9445-5C9B7ED3B1EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b27960e4f6759a32cc812a7fef65c39d1b2d0d44
P2860
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).